Valuation: T.S. Investment Corporation

Capitalization 55.77B 37.55M 32.38M 29.23M 28.04M 51.14M 3.45B 53.52M 346M 138M 1.65B 141M 138M 5.92B P/E ratio 2023
5.56x
P/E ratio 2024 -15.2x
Enterprise value 48.51B 32.66M 28.16M 25.42M 24.39M 44.48M 3B 46.55M 301M 120M 1.44B 123M 120M 5.15B EV / Sales 2023
2x
EV / Sales 2024 1.74x
Free-Float
60.75%
Yield 2023
0.71%
Yield 2024 1.09%
Dec. 25 T.S. Investment Corporation announced that it has received KRW 4.499997977 billion in funding from KX Innovation Co., Ltd., ODTech Co., Ltd. CI
Dec. 02 MGRV Inc. announced that it has received KRW 13 billion in funding from T.S. Investment Corporation, HB Investment, Inc. CI
Nov. 13 Semi Total Solution Inc agreed to acquire NH Special Purpose Acquisition 29 Company from T.S. Investment Corporation and others in a reverse merger transaction for KRW 54.5 billion. CI
Nov. 05 T.S. Investment Corporation announces Annual dividend, payable on April 30, 2026 CI
25-10-20 Senko Co., Ltd announced that it expects to receive KRW 5.999998072 billion in funding from T.S. Investment Corporation CI
25-08-25 The Hyoosik Co., Ltd. announced that it has received KRW 20 billion in funding from T.S. Investment Corporation CI
25-08-17 T.S. 2024-16 M&A Growh Fund, managed by T.S. Investment Corporation completed the acquisition of 14.74% stake in Senko Co., Ltd from Ha Seung Cheol. CI
25-07-14 Illimis Therapeutics, Inc. announced that it has received KRW 58 billion in funding from a group of investors CI
25-06-30 Senko Co., Ltd announced that it expects to receive KRW 4.499997872 billion in funding from T.S. Investment Corporation CI
25-06-30 T.S. 2024-16 M&A Growh Fund, managed by T.S. Investment Corporation signed an agreement to acquire 14.74% stake in Senko Co., Ltd from Ha Seung Cheol for KRW 17.7 billion. CI
25-06-08 Upvalue announced that it has received KRW 1 billion in funding from T.S. Investment Corporation CI
25-05-12 Samik Pharm. Co. Ltd agreed to acquire Hana 28 Special Purpose Acquisition Company from T.S. Investment Corporation and others in a reverse merger transaction for KRW 4.14 billion. CI
25-04-27 Genome & Company announced that it has received KRW 27.066097613 billion in funding from a group of investors CI
1 day+1.41%
1 week-8.49%
Current month-8.49%
1 month+35.45%
3 months+38.14%
6 months+34.00%
Current year+37.23%
1 week 1,601
Extreme 1601
2,075
1 month 1,385
Extreme 1385
2,320
Current year 1,205
Extreme 1205
2,320
1 year 1,026
Extreme 1026
2,865
3 years 801
Extreme 801
2,865
5 years 801
Extreme 801
6,520
10 years 786.67
Extreme 786.6667
6,520
Manager TitleAgeSince
Chief Executive Officer 56 -
Chief Executive Officer 60 -
Chief Investment Officer 56 2021-03-25
Director TitleAgeSince
Director/Board Member 56 -
Director/Board Member 60 -
Director/Board Member 57 2023-03-24
Change 5d. change 1-year change 3-years change Capi.($)
+1.41%-8.49%+54.02%-4.24% 55.57M
-1.65%+4.57%-19.50%-3.94% 2.7B
-1.14%-2.25%+11.74%-2.69% 1.85B
-0.13%-2.55%+57.14%+17.85% 1.08B
+4.69%+2.06%+354.64%+264.38% 798M
0.00%0.00%+2.66%-1.07% 684M
0.00%+3.37%-46.91%-73.62% 474M
-1.85%-0.38%-34.62%-25.84% 411M
0.00%-1.97%-0.67%0.00% 373M
+0.14%-11.82%+5.15%+50.54% 364M
Average +0.15%-1.75%+38.36%+22.14% 878.29M
Weighted average by Cap. -0.41%+0.34%+32.28%+21.22%

Financials

2023 2024
Net sales 25.49B 17.16M 14.8M 13.36M 12.82M 23.37M 1.58B 24.46M 158M 63.26M 756M 64.41M 63.03M 2.7B 17.28B 11.64M 10.03M 9.06M 8.69M 15.85M 1.07B 16.58M 107M 42.89M 513M 43.67M 42.74M 1.83B
Net income 10.32B 6.95M 5.99M 5.41M 5.19M 9.47M 639M 9.91M 63.96M 25.62M 306M 26.09M 25.53M 1.1B -2.44B -1.64M -1.42M -1.28M -1.23M -2.24M -151M -2.34M -15.1M -6.05M -72.33M -6.16M -6.03M -259M
Net Debt -6.31B -4.25M -3.66M -3.31M -3.17M -5.78M -390M -6.05M -39.08M -15.66M -187M -15.94M -15.6M -669M -7.26B -4.89M -4.22M -3.81M -3.65M -6.66M -449M -6.97M -44.99M -18.03M -216M -18.35M -17.96M -771M
Logo T.S. Investment Corporation
TS Investment Corp is a Korea-based venture capital investment company engaged in the investment in small and medium companies. The Company has invested in companies including Silicon Mitus, Wicket, Markpro, Redcap Tour, TurboTek, KAON, and Han Seo Pharm Co., Ltd.
Employees
-
Date Price Change Volume
26-03-06 1,876.00 +1.41% 772,208
26-03-05 1,850.00 +13.64% 1,071,373
26-03-04 1,628.00 -15.21% 2,156,281
26-03-03 1,920.00 -6.34% 2,342,498
26-02-27 2,050.00 +4.33% 9,273,102
  1. Stock Market
  2. Equities
  3. A246690 Stock